CARGO Therapeutics, Inc. Common StockCRGXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+218.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+218.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
32.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $143.40M | +89.2% |
| 2023 | $75.79M | +158.0% |
| 2022 | $29.37M | +558.4% |
| 2021 | $4.46M | - |